Erwin Ramos
Psychiatry · Vero Beach, FLNPI 1235396326
Payments from drug & device makers
What this record shows
This record is dominated by other: $8,405 of the $10,998 with a category attached, or 76.4%. Neuronetics, Inc. accounts for 77.7% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $8,833, more than ten times the $762 reported in 2019. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $84.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$9K
- Otsuka America Pharmaceutical, Inc.$519
- Corium, LLC$347
- Lundbeck LLC$330
- Takeda Pharmaceuticals U.S.A., Inc.$269
- Adlon Therapeutics L.p.$152
- plus $837 from 15 others
What the payments were for
- Food & beverage$2,56223%
- Education$310%
- Other$8,40576%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 5 | $8,544 |
| Otsuka America Pharmaceutical, Inc. | 21 | $519 |
| Corium, LLC | 16 | $347 |
| Lundbeck LLC | 21 | $330 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $269 |
| Adlon Therapeutics L.p. | 7 | $152 |
| AbbVie(2 entities) | 7 | $143 |
| Bausch Health US, LLC | 9 | $142 |
| Tris Pharma Inc | 5 | $142 |
| Almatica Pharma LLC | 4 | $96 |
| Eisai Inc. | 5 | $68 |
| Livanova USA, Inc. | 1 | $57 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$8,405
- Azstarys$125
- REXULTI$102
How this compares
$10,998 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 38 | $1,148 |
| Lorazepam | 45 | $610 |
| Lurasidone Hcl | 14 | $530 |
| Alprazolam | 49 | $362 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 23 | $349 |
| Lithium Carbonate | 18 | $274 |
| Amitriptyline Hcl | 19 | $230 |
| Zolpidem Tartrate | 11 | $176 |
| Clonazepam | 45 | $174 |
| Temazepam | 14 | $110 |
| Quetiapine Fumarate | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Vero Beach
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.